@article{hansen_lascelles_thomson_depuy_2013, title={Variability of performance of wound infusion catheters}, volume={40}, number={3}, journal={Veterinary Anaesthesia and Analgesia}, author={Hansen, B. and Lascelles, B. D. X. and Thomson, A. and DePuy, V.}, year={2013}, pages={308–315} }
 @article{lascelles_freire_roe_depuy_smith_marcellin-little_2010, title={Evaluation of Functional Outcome After BFX (R) Total Hip Replacement Using a Pressure Sensitive Walkway}, volume={39}, ISSN={["0161-3499"]}, url={https://dx.doi.org/10.1111/j.1532-950X.2009.00607.x}, DOI={10.1111/j.1532-950X.2009.00607.x}, abstractNote={OBJECTIVE
To evaluate stance phase limb use after cementless (BFX) total hip replacement (THR) in dogs and to relate postoperative radiographic variables to static bodyweight distribution after surgery.


STUDY DESIGN
Prospective clinical study.


ANIMALS
Dogs (n=35) that had THR.


METHODS
THR was performed using the BFX THR technique. Postoperative pain management regimens were similar for all dogs. Standing bodyweight distribution (%BW(distrib)) was measured using a pressure sensitive walkway and radiographs made before surgery and at 3, 6, and 12 months after surgery. Repeated measures models (with backwards-stepping to obtain the final model) were used for statistical analysis.


RESULTS
Temporally, %BW(distrib) to the operated limb increased (P<.0001; normal by 3 months) and decreased to the unoperated limb (P=.0001) and also increased to the pelvic limbs and decreased to the thoracic limbs. %BW(distrib) to the unoperated limb was significantly less than the operated limb at 3, 6, and 12 months after surgery. Postoperative canal fill and femur flare were significantly negatively correlated with change in %BW(distrib) (estimate=-0.24, P=.0413).


CONCLUSION
BFX THR results in normal %BW(distrib) to the operated limb by 3 months after surgery. A greater fill of the proximal femur may be associated with a suboptimal outcome.


CLINICAL RELEVANCE
BFX THR normalizes standing bodyweight distribution dogs with hip osteoarthritis. Objective evaluation of THR outcome and radiographic features may reveal factors that could be improved through changes in prosthesis design or surgical technique.}, number={1}, journal={VETERINARY SURGERY}, publisher={Blackwell Publishing Inc Malden, USA}, author={Lascelles, B. Duncan X. and Freire, Mila and Roe, Simon C. and DePuy, Venita and Smith, Eric and Marcellin-Little, Denis J.}, year={2010}, month={Jan}, pages={71–77} }
 @article{lascelles_hansen_roe_depuy_thomson_pierce_smith_rowinski_2007, title={Evaluation of client-specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis}, volume={21}, ISSN={["1939-1676"]}, DOI={10.1892/0891-6640(2007)21[410:EOCOMA]2.0.CO;2}, abstractNote={BACKGROUND
There are no validated systems for measuring pain from osteoarthritis in cats.


HYPOTHESIS
Owner subjective assessments and an activity monitor (AM) can be used to detect pain in cats with osteoarthritis and to assess efficacy of treatments.


ANIMALS
Thirteen cats older than 10 years old, with owner-assessed decreases in activity, painful arthritic joints, and clinically normal blood work were included and evaluated for 3 weeks.


METHODS
A collar-mounted AM measured activity and a client-specific outcome measure (CSOM) questionnaire characterized the severity of impairment. Overall global quality of life was also evaluated for each treatment. In weeks 2 and 3, meloxicam (0.1 mg/kg, day 1; 0.05 mg/kg, days 2-5) or a placebo was administered in a blinded, randomized, cross-over manner to test the assessment systems.


RESULTS
The cats had a median of 4 arthritic appendicular joints. Activity counts for the week when cats (complete data on activity; n=9) were administered meloxicam were significantly higher than at baseline (P = .02) but not after placebo (P = .06). Baseline activity counts were not significantly different from placebo (P = .6). The CSOM data (n=13) showed that owners considered their cats to be more active on meloxicam compared with baseline (P = .001) and placebo (P < .004), and more active on placebo than at baseline (P < .01). Global quality of life improved significantly with meloxicam (P < .042).


CONCLUSIONS AND CLINICAL IMPORTANCE
Both an AM and a CSOM system can detect behavior associated with pain relief in cats that are arthritic. Objective activity data might allow subjective assessment systems to be validated for use in clinical studies.}, number={3}, journal={JOURNAL OF VETERINARY INTERNAL MEDICINE}, author={Lascelles, B. Duncan X. and Hansen, Bernie D. and Roe, Simon and Depuy, Venita and Thomson, Andrea and Pierce, Courtney C. and Smith, Eric S. and Rowinski, Elizabeth}, year={2007}, pages={410–416} }
 @article{jaeger_marcellin-little_depuy_lascelles_2007, title={Validity of goniometric joint measurements in cats}, volume={68}, ISSN={["0002-9645"]}, url={https://dx.doi.org/10.2460/ajvr.68.8.822}, DOI={10.2460/ajvr.68.8.822}, abstractNote={Abstract}, number={8}, journal={AMERICAN JOURNAL OF VETERINARY RESEARCH}, author={Jaeger, Gayle H. and Marcellin-Little, Denis J. and DePuy, Venita and Lascelles, B. Duncan X.}, year={2007}, month={Aug}, pages={822–826} }